Step 1 topics → Gastrointestinal → Gastric Secretion and Cell Types

Gastric Secretion and Cell Types

USMLE Step 1 trap: Assigns pepsinogen secretion to parietal cells instead of chief cells. Chief cells secrete pepsinogen; parietal cells secrete HCl and intrinsic factor.

Gastric secretion and cell types is one of the most reliably high-yield physiology topics on USMLE Step 1. The stomach wall contains at least five distinct secretory cell types, each with a defined product, and the exam expects you to know all of them cold. But beyond simple recall, Step 1 pushes you to apply this knowledge: it will give you a clinical vignette about a patient with megaloblastic anemia and ask you to trace the defect back to a specific cell type, or it will show you a drug mechanism question that requires you to distinguish exactly where in the parietal cell signaling cascade an agent acts.

The trickiest part of this topic is the parietal cell itself, which is overloaded with testable details. It secretes both HCl and intrinsic factor, it receives three distinct stimulatory inputs (histamine, gastrin, acetylcholine) through two different G-protein pathways, and it is the direct target of PPIs. Students frequently mix up products between parietal and chief cells, and they tend to collapse all three parietal cell receptor pathways into one mechanism — both errors are heavily exploited by USMLE Step 1 question writers.

D cells (somatostatin), G cells (gastrin), and ECL cells (histamine) round out the picture and matter for regulation questions. The key to not losing points here is treating each cell type as a distinct entity with its own product, location, and regulatory role — and being precise about signaling: histamine uses Gs/cAMP, while gastrin and ACh use Gq/IP3/Ca²⁺. Those distinctions are exactly what separates correct answers from tempting distractors.

From real student decks
92%have cards covering this topic
76%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Parietal cells secrete pepsinogen.
Right: Chief cells secrete pepsinogen; parietal cells secrete HCl and intrinsic factor.
Chief cells are the pepsinogen factory — they sit in the lower part of gastric glands and release this zymogen, which gets activated to pepsin by the acidic environment that parietal cells create. Parietal cells are exclusively responsible for HCl and intrinsic factor; they have no role in pepsinogen secretion. Mixing these up matters clinically because the consequences of losing chief cells versus parietal cells are completely different on the exam.
Common mistake
Wrong: Pernicious anemia results from destruction of chief cells by autoantibodies.
Right: Pernicious anemia results from autoimmune destruction of parietal cells (or antibodies against intrinsic factor), leading to B12 malabsorption.
Pernicious anemia is an autoimmune attack on parietal cells (or on intrinsic factor itself via blocking antibodies) — not on chief cells. Because intrinsic factor is made only by parietal cells, their destruction eliminates the molecule required for ileal B12 absorption, leading to megaloblastic anemia. Chief cell destruction would impair protein digestion but would not cause B12 deficiency or megaloblastic changes.
Common mistake
Wrong: H2 blockers and PPIs both act directly on the H⁺/K⁺-ATPase proton pump.
Right: PPIs irreversibly inhibit the H⁺/K⁺-ATPase proton pump on parietal cells, while H2 blockers competitively block histamine H2 receptors, reducing cAMP-driven acid secretion.
These two drug classes act at entirely different points in the acid secretion pathway. H2 blockers (cimetidine, famotidine) competitively antagonize histamine at H2 receptors on the parietal cell surface, which reduces adenylyl cyclase activity and lowers cAMP — they never touch the pump itself. PPIs (omeprazole, lansoprazole) are prodrugs activated in the acidic canaliculus of the parietal cell; once activated, they covalently and irreversibly inhibit the H⁺/K⁺-ATPase, making them more potent and longer-lasting than H2 blockers.
Common mistake
Wrong: Gastrin stimulates parietal cells via a Gs-cAMP pathway like histamine.
Right: Gastrin and acetylcholine stimulate parietal cells via Gq-IP3/Ca²⁺ signaling, while histamine acts via Gs-cAMP; all three converge to activate the H⁺/K⁺-ATPase.
Histamine is the only one of the three parietal cell stimulants that uses Gs/cAMP — this is why H2 blockers are effective at reducing acid even when gastrin and ACh levels are normal. Gastrin (via CCK-B receptors) and acetylcholine (via M3 receptors) both couple to Gq, triggering phospholipase C, IP3, and intracellular Ca²⁺ release to activate the proton pump. Knowing this distinction explains why combining an H2 blocker with a muscarinic antagonist hits two separate pathways and why PPIs, which act downstream of all three inputs, are the most complete suppressors.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which secretory product belongs to each gastric cell type: parietal cells make HCl and intrinsic factor, chief cells make pepsinogen, G cells make gastrin, D cells make somatostatin, and ECL cells make histamine.
  2. Understand the three receptor inputs to the parietal cell (histamine via H2/Gs/cAMP, gastrin via CCK-B/Gq/Ca²⁺, acetylcholine via M3/Gq/Ca²⁺) and how drugs that block these inputs reduce acid output.
  3. Apply knowledge of parietal cell biology to clinical scenarios: recognize that pernicious anemia follows autoimmune parietal cell destruction (not chief cell loss), that PPIs block the H⁺/K⁺-ATPase directly and irreversibly, and that H2 blockers act upstream at the histamine receptor.

Can you avoid these mistakes?

A patient develops megaloblastic anemia and subacute combined degeneration of the spinal cord. Serologic testing reveals antibodies against gastric mucosal cells. Which specific cell type is being destroyed, what product of that cell is responsible for the neurologic findings, and how does its loss cause B12 deficiency?
A researcher treats isolated parietal cells with a drug and observes that intracellular cAMP rises but intracellular Ca²⁺ does not change. Which of the three physiologic stimulants is being mimicked, and what receptor/G-protein pathway is activated?
A patient with a gastric ulcer is started on omeprazole. A classmate argues that omeprazole works the same way as famotidine — both block acid by acting on parietal cell receptors. Where exactly is this reasoning wrong, and what is the correct molecular target and mechanism of each drug?
A pathology slide shows a cross-section of a gastric gland. Your attending points to cells at the surface, mid-gland, and base and asks you to identify each. Rank parietal cell, chief cell, G cell, D cell, and ECL cell by their location within the gastric gland and match each to its secretory product.

Related topics

Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →